Irene Oi-Lin Ng[Author] - Search Results

Year	Number of Results
2002	5
2003	16
2004	10
2005	8
2006	5
2007	6
2008	3
2009	8
2010	13
2011	16
2012	13
2013	13
2014	11
2015	12
2016	15
2017	14
2018	8
2019	12
2020	14
2021	19
2022	19
2023	16
2024	4

1

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.

Ho DW, Tsui YM, Chan LK, Sze KM, Zhang X, Cheu JW, Chiu YT, Lee JM, Chan AC, Cheung ET, Yau DT, Chia NH, Lo IL, Sham PC, Cheung TT, Wong CC, Ng IO. Ho DW, et al. Among authors: ng io. Nat Commun. 2021 Jun 17;12(1):3684. doi: 10.1038/s41467-021-24010-1. Nat Commun. 2021. PMID: 34140495 Free PMC article.

2

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC.

Wei L, Lee D, Law CT, Zhang MS, Shen J, Chin DW, Zhang A, Tsang FH, Wong CL, Ng IO, Wong CC, Wong CM. Wei L, et al. Among authors: ng io. Nat Commun. 2019 Oct 15;10(1):4681. doi: 10.1038/s41467-019-12606-7. Nat Commun. 2019. PMID: 31615983 Free PMC article.

3

Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer.

Zhang MS, Cui JD, Lee D, Yuen VW, Chiu DK, Goh CC, Cheu JW, Tse AP, Bao MH, Wong BPY, Chen CY, Wong CM, Ng IO, Wong CC. Zhang MS, et al. Among authors: ng io. Nat Commun. 2022 Feb 17;13(1):954. doi: 10.1038/s41467-022-28618-9. Nat Commun. 2022. PMID: 35177645 Free PMC article.

4

CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.

Chan CY, Chiu DK, Yuen VW, Law CT, Wong BP, Thu KL, Cescon DW, Soria-Bretones I, Cheu JW, Lee D, Tse AP, Zhang MS, Tan KV, Ng IO, Khong PL, Yau TC, Bray MR, Mak TW, Wong CC. Chan CY, et al. Among authors: ng io. Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2119514119. doi: 10.1073/pnas.2119514119. Epub 2022 Aug 1. Proc Natl Acad Sci U S A. 2022. PMID: 35914158 Free PMC article.

5

Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development.

Cheu JW, Chiu DK, Kwan KK, Yang C, Yuen VW, Goh CC, Chui NN, Shen W, Law CT, Li Q, Zhang MS, Bao MH, Wong BP, Chan CY, Liu CX, Sit GF, Ooi ZY, Deng H, Tse AP, Ng IO, Wong CC. Cheu JW, et al. Among authors: ng io. Sci Adv. 2023 May 5;9(18):eade5111. doi: 10.1126/sciadv.ade5111. Epub 2023 May 5. Sci Adv. 2023. PMID: 37146141 Free PMC article.

6

Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.

Chiu DK, Yuen VW, Cheu JW, Wei LL, Ting V, Fehlings M, Sumatoh H, Nardin A, Newell EW, Ng IO, Yau TC, Wong CM, Wong CC. Chiu DK, et al. Among authors: ng io. Gastroenterology. 2020 Aug;159(2):609-623. doi: 10.1053/j.gastro.2020.03.074. Epub 2020 Apr 8. Gastroenterology. 2020. PMID: 32275969

7

Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.

Tey SK, Wong SWK, Chan JYT, Mao X, Ng TH, Yeung CLS, Leung Z, Fung HL, Tang AHN, Wong DKH, Mak LY, Yuen MF, Sin CF, Ng IO, Ma SKY, Lee TKW, Cao P, Zhong K, Gao Y, Yun JP, Yam JWP. Tey SK, et al. Among authors: ng io. J Hepatol. 2022 Apr;76(4):883-895. doi: 10.1016/j.jhep.2021.12.005. Epub 2021 Dec 16. J Hepatol. 2022. PMID: 34922977 Free article.

8

Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.

Husain A, Chiu YT, Sze KM, Ho DW, Tsui YM, Suarez EMS, Zhang VX, Chan LK, Lee E, Lee JM, Cheung TT, Wong CC, Chung CY, Ng IO. Husain A, et al. Among authors: ng io. J Hepatol. 2022 Aug;77(2):383-396. doi: 10.1016/j.jhep.2022.02.018. Epub 2022 Feb 25. J Hepatol. 2022. PMID: 35227773 Free article.

9

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.

Cheu JW, Lee D, Li Q, Goh CC, Bao MH, Yuen VW, Zhang MS, Yang C, Chan CY, Tse AP, Sit GF, Liu CX, Ng IO, Wong CM, Wong CC. Cheu JW, et al. Among authors: ng io. Cell Mol Gastroenterol Hepatol. 2023;16(1):133-159. doi: 10.1016/j.jcmgh.2023.03.001. Epub 2023 Mar 7. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36893885 Free PMC article.

10

Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma.

Mok EHK, Leung CON, Zhou L, Lei MML, Leung HW, Tong M, Wong TL, Lau EYT, Ng IOL, Ding J, Yun JP, Yu J, Zhu HL, Lin CH, Lindholm D, Leung KS, Cybulski JD, Baker DM, Ma S, Lee TKW. Mok EHK, et al. Among authors: ng iol. Cancer Res. 2022 Sep 2;82(17):3102-3115. doi: 10.1158/0008-5472.CAN-21-2934. Cancer Res. 2022. PMID: 35767704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

230 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year